
Shareholder
Buchanan
Dr. Zhibin Li focuses his practices on complex intellectual property issues, with an emphasis on pharmaceutical Hatch-Waxman litigation. Zhibin has been involved in various aspects of such litigations, including:Paragraph IV Certifications,Non-infringement and invalidity contentions,Claim construction.
Additionally, Zhibin has experience in patent preparation, patent prosecution, and opinions on patentability, patent validity, patent infringement, and freedomto-operate.Zhibin's experience spans a wide range of technical areas within the life sciences, including pharmaceuticals, chemistry, nanomaterials, polymers, biotechnology and medical devices. Prior to joining the firm, Zhibin was a Principal Scientist at a major pharmaceutical company with research experience in solid form (polymorphs, salts and cocrystals) screening and API crystallization. In addition to his pharmaceutical experience and chemistry training, Zhibin also has extensive experience in material characterization using scattering (neutron, X-ray, light), microscopic (TEM, SEM, AFM, and optical) and thermo (DSC, TGA) methods in understanding materials with sizes ranging from nano- to micro-scale.